Literature DB >> 9312184

Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

L Rossetti1, A E Stenbit, W Chen, M Hu, N Barzilai, E B Katz, M J Charron.   

Abstract

Glucose transporter type 4 (GLUT4) is insulin responsive and is expressed in striated muscle and adipose tissue. To investigate the impact of a partial deficiency in the level of GLUT4 on in vivo insulin action, we examined glucose disposal and hepatic glucose production (HGP) during hyperinsulinemic clamp studies in 4-5-mo-old conscious mice with one disrupted GLUT4 allele [GLUT4 (+/-)], compared with wild-type control mice [WT (+/+)]. GLUT4 (+/-) mice were studied before the onset of hyperglycemia and had normal plasma glucose levels and a 50% increase in the fasting (6 h) plasma insulin concentrations. GLUT4 protein in muscle was approximately 45% less in GLUT4 (+/-) than in WT (+/+). Euglycemic hyperinsulinemic clamp studies were performed in combination with [3-3H]glucose to measure the rate of appearance of glucose and HGP, with [U-14C]-2-deoxyglucose to estimate muscle glucose transport in vivo, and with [U-14C]lactate to assess hepatic glucose fluxes. During the clamp studies, the rates of glucose infusion, glucose disappearance, glycolysis, glycogen synthesis, and muscle glucose uptake were approximately 55% decreased in GLUT4 (+/-), compared with WT (+/+) mice. The decreased rate of in vivo glycogen synthesis was due to decreased stimulation of glucose transport since insulin's activation of muscle glycogen synthase was similar in GLUT4 (+/-) and in WT (+/+) mice. By contrast, the ability of hyperinsulinemia to inhibit HGP was unaffected in GLUT4 (+/-). The normal regulation of hepatic glucose metabolism in GLUT4 (+/-) mice was further supported by the similar intrahepatic distribution of liver glucose fluxes through glucose cycling, gluconeogenesis, and glycogenolysis. We conclude that the disruption of one allele of the GLUT4 gene leads to severe peripheral but not hepatic insulin resistance. Thus, varying levels of GLUT4 protein in striated muscle and adipose tissue can markedly alter whole body glucose disposal. These differences most likely account for the interindividual variations in peripheral insulin action.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9312184      PMCID: PMC508369          DOI: 10.1172/JCI119711

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  69 in total

1.  Diverse effects of Glut 4 ablation on glucose uptake and glycogen synthesis in red and white skeletal muscle.

Authors:  A E Stenbit; R Burcelin; E B Katz; T S Tsao; N Gautier; M J Charron; Y Le Marchand-Brustel
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

Authors:  K Rebrin; G M Steil; S D Mittelman; R N Bergman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance.

Authors:  C Hollenbeck; G M Reaven
Journal:  J Clin Endocrinol Metab       Date:  1987-06       Impact factor: 5.958

Review 4.  Lilly lecture 1995. Glucose transport: pivotal step in insulin action.

Authors:  B B Kahn
Journal:  Diabetes       Date:  1996-11       Impact factor: 9.461

5.  Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM.

Authors:  R C Bonadonna; S Del Prato; E Bonora; M P Saccomani; G Gulli; A Natali; S Frascerra; N Pecori; E Ferrannini; D Bier; C Cobelli; R A DeFronzo
Journal:  Diabetes       Date:  1996-07       Impact factor: 9.461

6.  Insulin unmasks a COOH-terminal Glut4 epitope and increases glucose transport across T-tubules in skeletal muscle.

Authors:  W Wang; P A Hansen; B A Marshall; J O Holloszy; M Mueckler
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539

7.  Insulin resistance in essential hypertension.

Authors:  E Ferrannini; G Buzzigoli; R Bonadonna; M A Giorico; M Oleggini; L Graziadei; R Pedrinelli; L Brandi; S Bevilacqua
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

8.  Identification of a novel gene encoding an insulin-responsive glucose transporter protein.

Authors:  M J Birnbaum
Journal:  Cell       Date:  1989-04-21       Impact factor: 41.582

9.  Dose-response curves for in vivo insulin sensitivity in individual tissues in rats.

Authors:  E W Kraegen; D E James; A B Jenkins; D J Chisholm
Journal:  Am J Physiol       Date:  1985-03

10.  Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats.

Authors:  L Rossetti; D Smith; G I Shulman; D Papachristou; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

View more
  35 in total

Review 1.  Insights into insulin resistance and type 2 diabetes from knockout mouse models.

Authors:  T Kadowaki
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Skeletal muscle insulin resistance: is it important for the pathogenesis of type 2 diabetes after all?

Authors:  H A Koistinen; J R Zierath
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 3.  Role of histone methylation and demethylation in adipogenesis and obesity.

Authors:  Masashi Okamura; Takeshi Inagaki; Toshiya Tanaka; Juro Sakai
Journal:  Organogenesis       Date:  2010 Jan-Mar       Impact factor: 2.500

4.  Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents.

Authors:  Tammy L Kindel; Paulo J F Martins; Stephanie M Yoder; Ronald J Jandacek; Randy J Seeley; David A D'Alessio; Silvana Obici; Patrick Tso
Journal:  Obesity (Silver Spring)       Date:  2010-10-28       Impact factor: 5.002

5.  Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.

Authors:  J K Kim; A Zisman; J J Fillmore; O D Peroni; K Kotani; P Perret; H Zong; J Dong; C R Kahn; B B Kahn; G I Shulman
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

6.  Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice.

Authors:  J McKee Alderman; Kevin Flurkey; Natasha L Brooks; Sneha B Naik; Jonathan M Gutierrez; Urmila Srinivas; Kristen B Ziara; Linhong Jing; Gunnar Boysen; Rod Bronson; Simon Klebanov; Xian Chen; James A Swenberg; Mats Stridsberg; Carol E Parker; David E Harrison; Terry P Combs
Journal:  Exp Gerontol       Date:  2008-06-07       Impact factor: 4.032

7.  GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.

Authors:  Ko Kotani; Odile D Peroni; Yasuhiko Minokoshi; Olivier Boss; Barbara B Kahn
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

8.  Role of resistin in diet-induced hepatic insulin resistance.

Authors:  Evan D Muse; Silvana Obici; Sanjay Bhanot; Brett P Monia; Robert A McKay; Michael W Rajala; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

9.  Rab5 activity regulates GLUT4 sorting into insulin-responsive and non-insulin-responsive endosomal compartments: a potential mechanism for development of insulin resistance.

Authors:  Kandice L Tessneer; Robert M Jackson; Beth A Griesel; Ann Louise Olson
Journal:  Endocrinology       Date:  2014-06-16       Impact factor: 4.736

10.  Hepatic muscarinic acetylcholine receptors are not critically involved in maintaining glucose homeostasis in mice.

Authors:  Jian H Li; Dinesh Gautam; Sung-Jun Han; Jean-Marc Guettier; Yinghong Cui; Huiyan Lu; Chuxia Deng; James O'Hare; William Jou; Oksana Gavrilova; Christoph Buettner; Jürgen Wess
Journal:  Diabetes       Date:  2009-09-14       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.